Aston Pharmaceuticals: Prakruti R Pali Acquires 1.93% Stake

Prakruti R Pali has acquired an additional 1.93% stake in Aston Pharmaceuticals Limited. This transaction involved the purchase of 1,64,000 equity shares on August 28, 2026, via the open market. Following this acquisition, Prakruti R Pali’s total holding in Aston Pharmaceuticals now stands at 7.26% of the company’s total voting capital.

Shareholding Increase in Aston Pharmaceuticals

Prakruti R Pali has significantly increased their shareholding in Aston Pharmaceuticals Limited through a recent open market transaction. The acquisition, which took place on August 28, 2026, involved the purchase of 1,64,000 equity shares. This transaction represents an addition of 1.93% to Prakruti R Pali’s previously held stake in the company.

Current Holding Details

As of the post-acquisition period, Prakruti R Pali’s total holdings in Aston Pharmaceuticals now amount to 6,18,000 equity shares. This brings their total voting capital percentage in the company to 7.26%. The acquisition was completed through the Open Market mode, and the shares acquired are fully paid up equity shares. The total equity share capital of Aston Pharmaceuticals before the acquisition was 4,54,000 Equity Shares, and after the acquisition, it stands at 6,18,000 Equity Shares.

Source: BSE

Previous Article

Bharat Forge: Kalyani Powertrain Divests 50% Stake in REFU Drive GmbH

Next Article

The Phoenix Mills: AGM & Dividend Record Date Set for September 2026